Joseph Goldstein
Science Partner @ The Column Group
Joseph Goldstein is a startup investor at The Column Group. Goldstein and his colleague Michael Brown have worked together for the last 30 years on the genetics and regulation of cholesterol metabolism. Their discovery of the LDL receptor as the major molecule regulating cholesterol metabolism and its genetic disruption in the human disease familial hypercholesterolemia has been recognized by numerousawards, including the Albert D. Lasker Award in Basic Medical Research (1985), the Nobel Prize in Physiology or Medicine (1985), and the U.S. National Medal of Science (1988).More recently, Goldstein and Brown's discovery of the SREBP family of membrane-bound transcription factors and the elucidation of the proteolytic pathway by which the SREBPs become activated to regulate lipid metabolism was recognized by the receipt of the Albany Medical Prize in Biomedical Sciences in 2003.Goldstein has been a member of FivePrime’s Scientific Advisory Board since July 2002.
Last updated:
For AI agents: llms.txt
About The Column Group
The Column Group is a venture capital firm dedicated to creating the next generation of biotechnology companies. They manage over $4 billion in assets and focus on building companies with groundbreaking scientific platforms that have the potential to deliver significant new therapies for unmet medical needs. TCG takes a long-term approach, aimingto develop companies capable of generating multiple product opportunities rather than focusing on quick exits.
The Column Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Goeddel
Managing Partner
|
|||
Jeff Goater
Venture Partner
|
|||
|
Joseph Goldstein
Science Partner
|
|||
Millie Ray
Partner
|
|||
Peter Svennilson
Managing Partner and Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
